Search research articles
Contact Us
Filters
Showing results (11-20 of 31) with videos related to
Page
of 4
Sort By:
Nature Aging
|
March 22, 2024
Disease staging of Alzheimer's disease using a CSF-based biomarker model
Gemma Salvadó, Kanta Horie, Nicolas R Barthélemy, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 28, 2023
Novel CSF tau biomarkers can be used for disease staging of sporadic Alzheimer's disease
Gemma Salvadó, Kanta Horie, Nicolas R Barthélemy, et al.
Science Translational Medicine
|
November 16, 2022
APOE ε4 genotype, amyloid-β, and sex interact to predict tau in regions of high APOE mRNA expression
Aylin Dincer, Charles D Chen, Nicole S McKay, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 8, 2026
Identifying early changes in imaging, plasma, and digital cognitive biomarkers that correspond to Alzheimer's disease pathology in the presence of autopsy-confirmed co-pathologies
Charles D Chen, Cinthya Aguero, Alexandra Melloni, et al.
Ebiomedicine
|
March 29, 2024
Deconstructing pathological tau by biological process in early stages of Alzheimer disease: a method for quantifying tau spatial spread in neuroimaging
Stephanie Doering, Austin McCullough, Brian A Gordon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 11, 2022
Investigating Tau and Amyloid Tracer Skull Binding in Studies of Alzheimer Disease
Shaney Flores, Charles D Chen, Yi Su, et al.
Nature Medicine
|
February 21, 2024
Highly accurate blood test for Alzheimer's disease is similar or superior to clinical cerebrospinal fluid tests
Nicolas R Barthélemy, Gemma Salvadó, Suzanne E Schindler, et al.
Nature Medicine
|
July 13, 2023
CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer's disease
Kanta Horie, Gemma Salvadó, Nicolas R Barthélemy, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
June 30, 2025
Joint spatial associations of amyloid beta and tau pathology in Down syndrome and preclinical Alzheimer's disease: Cross-sectional associations with early cognitive impairments
Jessie Fanglu Fu, Arun Garimella, Alex Lapointe, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 23, 2025
Alzheimer's Imaging Consortium
Nelly Joseph-Mathurin, Charles D Chen, Diana A Hobbs, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 31) with videos related to
Sort By:
Page
of 4
Nature Aging
|
March 22, 2024
Disease staging of Alzheimer's disease using a CSF-based biomarker model
Gemma Salvadó, Kanta Horie, Nicolas R Barthélemy, et al.
Medrxiv : the Preprint Server for Health Sciences
|
July 28, 2023
Novel CSF tau biomarkers can be used for disease staging of sporadic Alzheimer's disease
Gemma Salvadó, Kanta Horie, Nicolas R Barthélemy, et al.
Science Translational Medicine
|
November 16, 2022
APOE ε4 genotype, amyloid-β, and sex interact to predict tau in regions of high APOE mRNA expression
Aylin Dincer, Charles D Chen, Nicole S McKay, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
January 8, 2026
Identifying early changes in imaging, plasma, and digital cognitive biomarkers that correspond to Alzheimer's disease pathology in the presence of autopsy-confirmed co-pathologies
Charles D Chen, Cinthya Aguero, Alexandra Melloni, et al.
Ebiomedicine
|
March 29, 2024
Deconstructing pathological tau by biological process in early stages of Alzheimer disease: a method for quantifying tau spatial spread in neuroimaging
Stephanie Doering, Austin McCullough, Brian A Gordon, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
August 11, 2022
Investigating Tau and Amyloid Tracer Skull Binding in Studies of Alzheimer Disease
Shaney Flores, Charles D Chen, Yi Su, et al.
Nature Medicine
|
February 21, 2024
Highly accurate blood test for Alzheimer's disease is similar or superior to clinical cerebrospinal fluid tests
Nicolas R Barthélemy, Gemma Salvadó, Suzanne E Schindler, et al.
Nature Medicine
|
July 13, 2023
CSF MTBR-tau243 is a specific biomarker of tau tangle pathology in Alzheimer's disease
Kanta Horie, Gemma Salvadó, Nicolas R Barthélemy, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
June 30, 2025
Joint spatial associations of amyloid beta and tau pathology in Down syndrome and preclinical Alzheimer's disease: Cross-sectional associations with early cognitive impairments
Jessie Fanglu Fu, Arun Garimella, Alex Lapointe, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 23, 2025
Alzheimer's Imaging Consortium
Nelly Joseph-Mathurin, Charles D Chen, Diana A Hobbs, et al.
Page
of 4